Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
EV to Sales: Premium ValuationElevated
Percentile Rank100
Studio
Year-over-Year Change

Enterprise value to sales ratio

Latest
9.80
↑ 384% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthElevated
Average
2.03
Historical baseline
PeriodValueYoY Change
20259.80+123.6%
20244.38-
20230.00-
20220.00-
20210.00-
20200.00-
20190.00-